Skip to main content
. 2019 Jun 3;15(9):2195–2204. doi: 10.1080/21645515.2018.1546523

Figure 3A.

Figure 3A.

Proportions of participants with a tetravalent response, by study month (per-protocol population).

Note: The arrows indicate when the study product (V180/placebo) was administered. The 0% data points for groups other than placebo are hidden by the placebo group. Tetravalent Response = FRNT50 titers ≥10 for all 4 DENV serotypes.Study Month 3 is 28 days Postdose 3.